Medacta Group SA
SIX:MOVE

Watchlist Manager
Medacta Group SA Logo
Medacta Group SA
SIX:MOVE
Watchlist
Price: 126.2 CHF -1.56% Market Closed
Market Cap: 2.5B CHF
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one MOVE stock under the Base Case scenario is 161.61 CHF. Compared to the current market price of 126.2 CHF, Medacta Group SA is Undervalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MOVE Relative Value
Base Case
161.61 CHF
Undervaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.8
P/S
P/S
Price to Sales
4.8
vs History
55
vs Industry
26
Median 3Y
4.9
Median 5Y
5.1
Industry
2.2
Forward
4.5
More Details
46.8
P/E
P/E
Price to Earnings
46.8
vs History
50
vs Industry
10
Median 3Y
45
Median 5Y
49.1
Industry
22.5
Forward
35.9
More Details
33.1
P/OCF
P/OCF
Price to OCF
33.1
vs History
41
vs Industry
10
Median 3Y
31.9
Median 5Y
33
Industry
13.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
0
Median 3Y
-362
Median 5Y
-55.9
Industry
19.7
More Details
7.7
P/B
P/B
Price to Book Value
7.7
vs History
65
vs Industry
9
Median 3Y
7.7
Median 5Y
8.6
Industry
2.1
More Details
5.2
EV/S
EV/S
Enterprise Value to Sales
5.2
vs History
57
vs Industry
23
Median 3Y
5.2
Median 5Y
5.4
Industry
2.3
Forward
4.7
More Details
7.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.6
vs History
53
vs Industry
29
Median 3Y
7.6
Median 5Y
7.8
Industry
4.9
More Details
20.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
20.1
vs History
49
vs Industry
17
Median 3Y
19.6
Median 5Y
20.2
Industry
11.9
Forward
17.8
More Details
36.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
36.1
vs History
31
vs Industry
12
Median 3Y
33.7
Median 5Y
34.5
Industry
16.4
Forward
30.9
More Details
35.4
EV/OCF
EV/OCF
Enterprise Value to OCF
35.4
vs History
39
vs Industry
10
Median 3Y
33.7
Median 5Y
34.7
Industry
13.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
0
Median 3Y
-161.3
Median 5Y
-150
Industry
17.2
More Details
4.2
EV/IC
EV/IC
Enterprise Value to IC
4.2
vs History
57
vs Industry
19
Median 3Y
4.2
Median 5Y
4.4
Industry
1.8
More Details

Multiples Across Competitors

MOVE Competitors Multiples
Medacta Group SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Medacta Group SA
SIX:MOVE
2.6B CHF 4.8 46.8 20.1 36.1
US
Abbott Laboratories
NYSE:ABT
228.5B USD 5.4 17 22.8 33.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.6B USD 21.6 77.8 60.3 73.1
US
Boston Scientific Corp
NYSE:BSX
147.4B USD 8.8 79.5 36.4 51.3
US
Stryker Corp
NYSE:SYK
144B USD 6.4 48.1 24.9 30.1
IE
Medtronic PLC
NYSE:MDT
114B USD 3.4 26.8 14.2 20.1
US
Becton Dickinson and Co
NYSE:BDX
65.4B USD 3.2 37.4 15.6 28.1
DE
Siemens Healthineers AG
XETRA:SHL
56.1B EUR 2.5 28.2 16.2 23.1
US
Edwards Lifesciences Corp
NYSE:EW
42.3B USD 7.8 10.1 23.8 26.3
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
278.7B CNY 7.5 22.5 19.6 19.6
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.2B USD 1.8 18.2 12.7 15.6

See Also

Summary
MOVE intrinsic value, competitors valuation, and company profile.
DCF Valuation
MOVE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MOVE stock valuation using valuation multiples.
Wall Street Estimates
MOVE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MOVE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 243,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.